Drawing for BIOKORF

USPTO serial 87477289

BIOKORF

Reviewed by CopyMark Law Group

Reg. 6486448Status 700Renewal
Filing date
Status date
Registration date
Sep 14, 2021
Examiner
DIBLE, JONATHON I
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with BIOKORF?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of mental abnormalities; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of hormone replacement; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, antidepressants; Pharmaceuticals, namely, antihelmintics; Pharmaceuticals, namely, psychotropics; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of films that facilitate the delivery of pharmaceutical preparations; Unit dose capsules sold empty for pharmaceutical useACTIVEOct 12, 2020
042Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research on the subject of pharmaceuticalsACTIVEOct 12, 2020
044Pharmaceutical advice; Pharmaceutical compounding services; Dispensing of pharmaceuticalsACTIVEOct 12, 2020

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (R.PR): Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.

DateCodeEventWhat it means
Sep 14, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 10, 2021SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Aug 9, 2021CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 16, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jul 16, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 14, 2021ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 18, 2021GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
Jan 18, 2021GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 18, 2021CNFRSU - FINAL REFUSAL - WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 29, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Dec 29, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 21, 2020ALIEASSIGNED TO LIE
Dec 11, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 21, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 21, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 21, 2020CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 15, 2020SUPCSTATEMENT OF USE PROCESSING COMPLETE
Oct 13, 2020IUAFUSE AMENDMENT FILED
Oct 13, 2020EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 29, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 28, 2020EX5GSOU EXTENSION 5 GRANTED
Aug 21, 2020NREVNOTICE OF REVIVAL - E-MAILED
Aug 20, 2020TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION
Aug 20, 2020PETGPETITION TO REVIVE-GRANTED
Aug 20, 2020PROATEAS PETITION TO REVIVE RECEIVED
Aug 3, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 3, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 23, 2020DOCKASSIGNED TO EXAMINER
Jul 2, 2020EXT5SOU EXTENSION 5 FILED
Mar 10, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 9, 2020EX4GSOU EXTENSION 4 GRANTED
Mar 7, 2020NREVNOTICE OF REVIVAL - E-MAILED
Mar 6, 2020TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION
Mar 6, 2020PETGPETITION TO REVIVE-GRANTED
Mar 6, 2020PROATEAS PETITION TO REVIVE RECEIVED
Feb 3, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 3, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 2, 2020EXT4SOU EXTENSION 4 FILED
Nov 13, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 12, 2019EX3GSOU EXTENSION 3 GRANTED
Oct 7, 2019NREVNOTICE OF REVIVAL - E-MAILED
Oct 7, 2019TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION
Oct 7, 2019PETGPETITION TO REVIVE-GRANTED
Oct 7, 2019PROATEAS PETITION TO REVIVE RECEIVED
Aug 5, 2019MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 5, 2019ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 2, 2019EXT3SOU EXTENSION 3 FILED
Apr 9, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 8, 2019EX2GSOU EXTENSION 2 GRANTED
Apr 5, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 2, 2019NREVNOTICE OF REVIVAL - E-MAILED
Mar 2, 2019TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION
Mar 2, 2019PETGPETITION TO REVIVE-GRANTED
Mar 2, 2019PROATEAS PETITION TO REVIVE RECEIVED
Feb 4, 2019MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 4, 2019ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 2, 2019EXT2SOU EXTENSION 2 FILED
Jun 30, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 28, 2018EX1GSOU EXTENSION 1 GRANTED
Jun 28, 2018EXT1SOU EXTENSION 1 FILED
Jun 28, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 2, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 7, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 7, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 18, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 29, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 7, 2017XAECEXAMINER'S AMENDMENT ENTERED
Sep 7, 2017ALIEASSIGNED TO LIE
Sep 7, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 7, 2017GNEAEXAMINERS AMENDMENT E-MAILED
Sep 7, 2017CNEAEXAMINERS AMENDMENT -WRITTEN
Sep 6, 2017DOCKASSIGNED TO EXAMINER
Jun 14, 2017MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 13, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 9, 2017NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance